ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

INDP Indaptus Therapeutics Inc

2,65
0,0181 (0,69%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Indaptus Therapeutics Inc INDP NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,0181 0,69% 2,65 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,69 2,55 2,70 2,65 2,6319
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/06/202409:00GLOBEIndaptus Therapeutics to Present New Positive Data on..
03/06/202409:00GLOBEIndaptus Therapeutics Announces New Positive Data from..
30/05/202409:00GLOBEIndaptus Therapeutics to Present at the Jefferies Global..
29/05/202409:00GLOBEIndaptus Therapeutics to Present New Cohort Data Confirming..
22/05/202409:00GLOBEIndaptus Therapeutics Announces Completion of First Patient..
08/05/202409:00GLOBEIndaptus Therapeutics Reports First Quarter 2024 Financial..
11/04/202408:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
28/03/202409:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
25/03/202409:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
18/03/202409:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
13/03/202408:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
04/03/202409:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
15/02/202410:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
08/02/202410:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
04/01/202410:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
06/11/202318:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
06/11/202310:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
31/10/202310:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
27/09/202309:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
26/09/202309:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
19/09/202309:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
06/09/202309:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
14/08/202309:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
10/08/202309:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
07/08/202309:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
15/06/202309:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..

Seu Histórico Recente

Delayed Upgrade Clock